Azek Insider Sold Shares Worth $627,958, According to a Recent SEC Filing-February 2024-www.financetom.com

Azek Insider Sold Shares Worth $627,958, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Azek Insider Sold Shares Worth $627,958, According to a Recent SEC Filing

Apr 12, 2024 1:39 PM

04:19 PM EDT, 04/12/2024 (MT Newswires) -- Jesse G Singh, Director, CEO and President, on April 10, 2024, sold 13,000 shares in Azek ( AZEK ) for $627,958. Following the Form 4 filing with the SEC, Singh has control over a total of 1,741,625 shares of the company, with 1,083,444 shares held directly and 658,181 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1782754/000162828024016047/xslF345X03/wk-form4_1712952633.xml

Price: 47.29, Change: -0.01, Percent Change: -0.02

Previous page： Palo Alto Networks Insider Sold Shares Worth $16,082,453, According to a Recent SEC Filing Next page： United Therapeutics Insider Sold Shares Worth $4,727,736, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Palo Alto Networks Insider Sold Shares Worth $16,082,453, According to a Recent SEC Filing

Apr 9, 2024

04:41 PM EDT, 04/09/2024 (MT Newswires) -- Lee Klarich, Executive Vice President, Chief Product Officer, on April 05, 2024, sold 60,000 shares in Palo Alto Networks ( PANW ) for $16,082,453. Following the Form 4 filing with the SEC, Klarich has control over a total of 574,075 shares of the company, with 174,075 shares held directly and 400,000 controlled indirectly....

United Therapeutics Insider Sold Shares Worth $4,727,736, According to a Recent SEC Filing

Apr 9, 2024

04:40 PM EDT, 04/09/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on April 05, 2024, sold 20,060 shares in United Therapeutics ( UTHR ) for $4,727,736. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 130 shares of the company, with 130 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000141588924010571/xslF345X03/form4-04092024_040402.xml ...

Shell at disadvantage to US-listed rivals, says former CEO

Apr 9, 2024

LAUSANNE, Switzerland, April 9 (Reuters) - Shell's former CEO, Ben van Beurden, said on Tuesday that European oil and gas companies will find it increasingly difficult to compete with U.S.-listed rivals. There are a deeper pool of investors and capital in New York and the attitude is more positive towards oil and gas companies, van Beurden, who stepped down in...

Cytokinetics Insider Sold Shares Worth $2,422,918, According to a Recent SEC Filing

Apr 9, 2024

04:42 PM EDT, 04/09/2024 (MT Newswires) -- Fady Ibraham Malik, Executive Vice President, Research & Development, on April 09, 2024, sold 32,605 shares in Cytokinetics ( CYTK ) for $2,422,918. Following the Form 4 filing with the SEC, Malik has control over a total of 138,567 shares of the company, with 138,567 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1061983/000112760224012715/xslF345X03/form4.xml Price: 75,...